Home › Funds › JOHNSON & JOHNSON › PRCT
JOHNSON & JOHNSON position in PRCT
PROCEPT BIOROBOTICS CORP · Health Care
JOHNSON & JOHNSON reported holding 357,939 shares of PRCT (PROCEPT BIOROBOTICS CORP) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.86% of its reported portfolio and ranking #11 among its reported holdings. JOHNSON & JOHNSON has disclosed PRCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JOHNSON & JOHNSON's PRCT position evolved
JOHNSON & JOHNSON first disclosed a stake in PRCT in Q3 2023 at 357,939 shares (US$11.7M). The position peaked in Q4 2024 at 357,939 shares, worth US$28.8M. Across 13 filings, JOHNSON & JOHNSON held the position steady without any share-count change. The most recent filing (Q3 2026) shows 357,939 shares valued at US$6.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 357.94K | $11.74M | New |
| Q4 2023 | 357.94K | $15.00M | Hold |
| Q1 2024 | 357.94K | $17.69M | Hold |
| Q2 2024 | 357.94K | $21.87M | Hold |
| Q3 2024 | 357.94K | $28.68M | Hold |
| Q4 2024 | 357.94K | $28.82M | Hold |
| Q1 2025 | 357.94K | $20.85M | Hold |
| Q2 2025 | 357.94K | $20.37M | Hold |
| Q3 2025 | 357.94K | $12.77M | Hold |
| Q4 2025 | 357.94K | $11.26M | Hold |
| Q1 2026 | 357.94K | $8.95M | Hold |
| Q2 2026 | 357.94K | $8.08M | Hold |
| Q3 2026 | 357.94K | $6.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PRCT and 13F data
PRCT (PROCEPT BIOROBOTICS CORP) is a Health Care company. 17 other funds we track also report a position in PRCT — the largest reported positions include Soleus Capital Management, L.P. (US$22.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PRCT
- Soleus Capital Management, L.P. 1.00M sh · $22.65M · Q2 2026
More on JOHNSON & JOHNSON
FAQ
How long has JOHNSON & JOHNSON held PRCT?
JOHNSON & JOHNSON has disclosed PRCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JOHNSON & JOHNSON's current position in PRCT?
As of Q3 2026, JOHNSON & JOHNSON holds 357.94K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $6.52M, representing 0.86% of its reported portfolio and ranking #11.
Has JOHNSON & JOHNSON been buying or selling PRCT?
In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in PRCT. The position peaked in Q4 2024 at 357.94K shares.
Which other funds hold PRCT?
Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.